Related Posts
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
The pharmacy industry sees at least five changes
Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Charitable Pharmacies of America organization member receives Health Equity grant
The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming
How Many People Might Lose Medicaid When States Unwind Continuous Enrollment?
There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.
Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections
Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?
St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

